These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30193216)

  • 41. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
    Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
    Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
    Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
    Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticancer activity of VDR-coregulator inhibitor PS121912.
    Sidhu PS; Teske K; Feleke B; Yuan NY; Guthrie ML; Fernstrum GB; Vyas ND; Han L; Preston J; Bogart JW; Silvaggi NR; Cook JM; Singh RK; Bikle DD; Arnold LA
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):787-98. PubMed ID: 25107568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents.
    Wei Q; Li J; Tang F; Yin Y; Zhao Y; Yao Q
    Eur J Med Chem; 2018 Jan; 144():504-516. PubMed ID: 29288947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.
    Ma Y; Khalifa B; Yee YK; Lu J; Memezawa A; Savkur RS; Yamamoto Y; Chintalacharuvu SR; Yamaoka K; Stayrook KR; Bramlett KS; Zeng QQ; Chandrasekhar S; Yu XP; Linebarger JH; Iturria SJ; Burris TP; Kato S; Chin WW; Nagpal S
    J Clin Invest; 2006 Apr; 116(4):892-904. PubMed ID: 16528410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
    Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
    Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a new cyathane diterpene that induces mitochondrial and autophagy-dependent apoptosis and shows a potent in vivo anti-colorectal cancer activity.
    He L; Han J; Li B; Huang L; Ma K; Chen Q; Liu X; Bao L; Liu H
    Eur J Med Chem; 2016 Mar; 111():183-92. PubMed ID: 26871659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.
    Li D; Xu S; Cai H; Pei L; Wang L; Wu X; Yao H; Jiang J; Sun Y; Xu J
    ChemMedChem; 2013 May; 8(5):812-8. PubMed ID: 23520191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
    Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
    J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies.
    Brandi G; Fraternale A; Lucarini S; Paiardini M; De Santi M; Cervasi B; Paoletti MF; Galluzzi L; Duranti A; Magnani M
    Anticancer Agents Med Chem; 2013 May; 13(4):654-62. PubMed ID: 23092288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds.
    Wang J; Yun D; Yao J; Fu W; Huang F; Chen L; Wei T; Yu C; Xu H; Zhou X; Huang Y; Wu J; Qiu P; Li W
    Eur J Med Chem; 2018 Jan; 144():493-503. PubMed ID: 29288946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
    Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
    Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway.
    Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD
    Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.
    Jiang Y; Li X; Hou J; Huang Y; Wang X; Jia Y; Wang Q; Xu W; Zhang J; Zhang Y
    Eur J Med Chem; 2018 Jan; 143():334-347. PubMed ID: 29202398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D₂ as Potential Anti-Leukemic Agents.
    Corcoran A; Nadkarni S; Yasuda K; Sakaki T; Brown G; Kutner A; Marcinkowska E
    Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26840307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening.
    Shen J; Jiang J; Kuang G; Tan C; Liu G; Huang J; Tang Y
    Eur J Med Chem; 2012 Aug; 54():188-96. PubMed ID: 22647217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.
    Brard L; Lange TS; Robison K; Kim KK; Ara T; McCallum MM; Arnold LA; Moore RG; Singh RK
    Gynecol Oncol; 2011 Nov; 123(2):370-8. PubMed ID: 21803404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.